Subscribe To
Shareholder investigation: halper sadeh llc investigates slgc, sp, mrtx
NEW YORK, Nov. 04, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential vio...
November 4, 2023, 4:00 am
Stockholder alert: the m&a class action firm continues investigating the merger – six, mrtx, faze, tgh
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the �...
November 3, 2023, 9:40 pm
Stockholder alert: the m&a class action firm continues investigating the merger – mrtx, faze, hes, tgh
NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) — Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the �...
October 27, 2023, 10:00 pm
Shareholder investigation: halper sadeh llc investigates pnt, mrtx, ortx
NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential vio...
October 26, 2023, 5:23 pm
Bristol-myers squibb acquisition of mirati makes sense
Bristol Myers Squibb is a large pharmaceutical company with a strong dividend yield and impressive assets. The company's recent acquisition of Mirati ...
October 22, 2023, 8:53 am
Shareholder investigation: halper sadeh llc investigates sp, mrtx, icpt
NEW YORK, Oct. 21, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential vio...
October 22, 2023, 1:28 am
Shareholder investigation: halper sadeh llc investigates sp, olk, ortx, mrtx
NEW YORK, Oct. 17, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential vio...
October 17, 2023, 11:59 pm
Moore kuehn encourages sp, ortx, mrtx, and srt investors to contact law firm
NEW YORK, Oct. 17, 2023 (GLOBE NEWSWIRE) — Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New Yo...
October 17, 2023, 10:03 pm
Shareholder investigation: halper sadeh llc investigates mrtx, nwli, pwfl
NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential vio...
October 11, 2023, 11:08 am
Analysts target biotech name on buyout buzz
Mirati Therapeutics Inc (NASDAQ:mrtx) stock is dropping today, after news that Bristol-Myers Squibb (BM...
October 9, 2023, 3:03 pm
Pharma stock nears 2-year low on multi-billion dollar deal
Shares of major pharmaceutical name Bristol-Meyers Squibb Co (NYSE:BMY) are 0.2% lower at $56.54 at last glance, and touched a nearly two-year low of...
October 9, 2023, 2:10 pm
Brodsky & smith shareholder update: notifying investors of the following investigations: mirati therapeutics, inc.® (nasdaq – mrtx), livevox holdings, inc. (nasdaq – lvox), sp® plus corporation (nasda
BALA CYNWYD, Pa., Oct. 09, 2023 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to ...
October 9, 2023, 2:08 pm
Bristol-myers is spending $5.8 billion to buy mirati therapeutics
Bristol-Myers Squibb Co (NYSE: BMY) has decided to spend up to $5.8 billion to acquire Mirati Therapeutics Inc (NASDAQ: ...
October 9, 2023, 1:04 pm
Bristol-myers squibb buys mirati therapeutics to boost cancer drug portfolio
Bristol-Myers Squibb (BMY) moved to expand its reach into cancer-fighting drugs by buying Mirati Therapeutics (...
October 9, 2023, 12:05 pm
Bristol-myers squibb to acquire mirati in deal worth up to $5.8b
Bristol-Myers Squibb (BMY) agreed to buy cancer drugmaker Mirati Therapeutics (mrtx) for up to $5.8 bil...
October 9, 2023, 10:48 am
Bristol-myers squibb enhances oncology portfolio in deal worth up to $5.8bn
Bristol-Myers Squibb Co (NYSE:BMY) has unveiled plans to buy Mirati Therapeutics (NASDAQ:mrtx) in a de...
October 9, 2023, 6:16 am
Bristol-myers squibb enahnces oncology portfolio in deal worth up to $5.8bn
Bristol-Myers Squibb Co (NYSE:BMY) has unveiled plans to buy Mirati Therapeutics (NASDAQ:mrtx) in a de...
October 9, 2023, 3:21 am
Mirati (mrtx) surges 45% as sanofi reportedly eyes buyout
A Bloomberg article suggests that pharma giant Sanofi (SNY) is exploring a potential acquisition deal for small cancer drugmaker Mirati Therapeutics (...
October 6, 2023, 12:47 pm
Mirati (mrtx) soars 12.3%: is further upside left in the stock?
Mirati (mrtx) saw its shares surge in the last session with trading volume being higher than average. T...
September 22, 2023, 6:01 am
Mirati (mrtx) q2 earnings beat, stock up on solid krazati sales
Mirati (mrtx) reports better-than-expected second-quarter earnings while revenues miss by a slight marg...
August 9, 2023, 11:27 am